Spectrum Dynamics Medical

22/10/2026

Thank you for an unforgettable !

From welcoming visitors at our booth to bringing the community together for our user meeting and lunch symposium, it was a pleasure connecting with so many colleagues, customers, and partners in Vienna.

Thank you to everyone who joined us and helped make the conference so memorable. We look forward to continuing these conversations!

European Association of Nuclear Medicine - EANM

15/10/2026

After launching in July, our All-Energy Enhancement for the VERITON-CT 400 has now completed initial clinical experience at four leading institutions: Florida Theranostics, Schneider Children's Medical Center of Israel, Huntsman Cancer Institute and CHRU de Nancy.

Across all four sites, it delivered all-energy theranostics imaging without compromising diagnostic performance.

With that milestone, we’re giving it its own name: VERITON-CT 400 All-Energy.

Here’s what we learned at each site:
🔹 Florida Theranostics: Diagnosis through therapy on one scanner. Tc-99m, I-123, Lu-177 and whole-body I-131, with no second system needed.
🔹 Schneider Children’s: More studies with no trade-off in performance. Results were equal or superior to conventional SPECT in high-dose I-131 and a wide range of Tc-99m studies.
🔹 Huntsman Cancer Institute: A first look at imaging actinium. Ac-225 is one of the hardest therapeutic isotopes to image, and its daughter isotope emissions were visualized in phantom studies.
🔹 CHRU de Nancy: High-energy imaging in routine clinical practice. Whole-body I-131 imaging three days after therapy, as well as other key radioisotopes, on digital CZT.

Thank you to Dr. Ashok MuthuKrishnan, Dr. Zvi Bar-Sever, Pr. Laetitia Imbert and Dr. Jeffrey Yap, along with their clinical teams, for their collaboration and contributions to these initial experiences.

Look for a post tomorrow featuring some of our best clinical images from this initial set of experiences.

Read the full press release: https://www.prnewswire.com/news-releases/four-leading-institutions-complete-initial-clinical-experience-with-spectrum-dynamics-medicals-all-energy-digital-spectct-302909444.html

If you’re attending EANM 2026 in Vienna, be sure to connect with us:
📍 Booth 509, Hall X5
🎤 Lunch symposium: “Driving Precision Nuclear Medicine with 360° CZT SPECT/CT,” Monday, Oct. 19, 13:15–14:45, Hall E2, with Pr. Denis Agostini, Pr. Laetitia Imbert, Pr. Désirée Deandreis and Dr. Daniel Juneau

Experience at institutions from across the globe demonstrated theranostics and imaging across the validated 40-400 keV range and up to 500 keV, with additional...

14/10/2026

Actinium-225 is one of the hardest isotopes in nuclear medicine to image.

Ac-225 is driving a lot of excitement in targeted alpha therapy. But the gamma photons you image come from its daughters, Francium-221 at 218 keV and Bismuth-213 at 440 keV. Those emissions are high-energy and low-abundance, and the injected activity is only a few MBq.

That makes reliable quantitative SPECT very hard. Pharma teams and CROs running Ac-225 programs know this well.

So, we put it to the test.

At Huntsman Cancer Institute at the University of Utah, Dr. Jeffrey Yap and the Center for Quantitative Cancer Imaging and Theranostics imaged a Graves phantom filled with 3.7 MBq of Ac-225. They used VERITON-CT 400 with our new All-Energy enhancement.

The results:
🔹Both daughter peaks were clearly imaged in a single study.
🔹Fr-221 (218 keV): Less Than +/- 10% Error in Integral Activity
🔹Bi-213 (440 keV): Less Than +/- 10% Error in Integral Activity
🔹Quantitative accuracy held in both energy windows, which is the foundation for Ac-225 dosimetry.

For teams developing alpha therapies, this opens a practical route to quantitative Ac-225 imaging in clinical trials and, eventually, in routine care.

Thank you to Dr. Yap and the Huntsman team for their partnership and rigor.

13/10/2026

We are pleased to announce the installation of a second VERITON-CT at Sahlgrenska University Hospital, this time at the new Department of Clinical Physiology at Östra Sjukhuset.

The clinical team made an impressive start, progressing from training to patient imaging during the very first week. Examinations performed included DaTscan, whole-body and three-phase bone scans, amyloidosis imaging, and parathyroid imaging.

This rapid transition into clinical use reflects the dedication of the team and the strength of the collaboration behind the project.

We extend our sincere thanks to the biomedical engineers, medical physicists, technologists (BMA), physiologists, management team, civil works teams, project management, and everyone else who contributed to the successful installation.

Congratulations to the entire team at Östra Sjukhuset on this exciting milestone!

12/10/2026

Only one week until our lunch symposium, a discussion you won’t want to miss!

Join us in Vienna to explore how 360° CZT SPECT/CT is expanding possibilities across nuclear medicine, from quantitation and artificial intelligence to high-energy imaging, oncology, theranostics, and clinical workflow.

Professor Denis Agostini, MD, PhD, will moderate the discussion with Professor Laetitia Imbert, PhD, Professor Desiree Deandreis, MD, PhD, and Daniel Juneau, MD, who will share clinical and research perspectives on translating advanced imaging capabilities into practice.

📅 Monday, October 19
🕐 13:15–14:45
📍 Hall E2

Lunch will be provided. We look forward to welcoming you!

European Association of Nuclear Medicine - EANM

07/10/2026

Another powerful example of all-energy imaging in clinical practice.

We are pleased to share whole-body I-131 images acquired at CHRU de Nancy on the VERITON-CT 400 Series with the All-Energy Enhancement. The images were acquired three days after treatment with an administered activity of 30 mCi.

“The All-Energy Enhancement for the VERITON-CT 400 Series enabled us to significantly improve the capabilities of our digital CZT SPECT/CT platform to high-energy I-131 imaging. This is an exciting development for post-treatment imaging and its integration into clinical practice,” said Pr. Laetitia Imbert.

A special thank you to Pr. Laetitia Imbert, Pr. Pierre-Yves Marie, and the entire team at CHRU de Nancy for their continued collaboration and for allowing us to share these images.

Attending EANM 2026? Visit Spectrum Dynamics Medical to view more clinical images and learn how the All-Energy Enhancement is expanding the possibilities of digital SPECT/CT imaging.

More clinical images from the All-Energy Enhancement are coming soon!

06/10/2026

For a patient, it's finally getting answers.
For a physician, it's confidence in the next decision.
For a family, it's a reason to feel optimistic about what's ahead.

That's why this year's Nuclear Medicine & Molecular Imaging Week theme, "Radiating Hope," feels so fitting. Nuclear medicine helps people find answers, discover options, and move forward when they need it most.

This week, we're celebrating the clinicians, technologists, physicists, researchers, and healthcare teams who make that possible every day.

Thank you for the difference you make.

Happy Nuclear Medicine & Molecular Imaging Week! 💙

02/10/2026

October is shaping up to be a busy month for the Spectrum Dynamics Medical team! We look forward to connecting with colleagues at these upcoming events across Europe:

📍 30èmes Journées d’Ingénierie Biomédicale de l’AFIB
Rennes, France | October 7-9
Connect with Jérôme Lavaure and Xavier Alaux

📍 Nuclear Medicine Day Brussels
Brussels, Belgium | October 8
Connect with Gaetan Van Simaeys

📍 Kurs für kardiovaskuläre Nuklearmedizin / Nuklear-Kardiologie
Stuttgart, Germany | October 8-9
Connect with Stefan Dirks

📍 EANM 2026
Vienna, Austria | October 17-21
Connect with Olivier Cannet or your local SDM representative

Will you be attending? Reach out to our team to arrange a time to meet. We look forward to seeing you there!

European Association of Nuclear Medicine - EANM

30/09/2026

VERITON-CT 316 is now installed and in clinical use at Fujita Health University Hospital in Japan!

During its first two days of clinical use, the hospital completed 10 patient studies across bone, thyroid, and kidney imaging.

Congratulations to everyone involved in reaching this important milestone. We look forward to continuing our collaboration with the Fujita Health University Hospital team as they advance their nuclear medicine imaging capabilities.

25/09/2026

Highlights from ECMP 2026!

Yesterday, Rafael Baavour, VP of Science and Innovation at Spectrum Dynamics Medical, shared insights on single-collimator performance across diverse energy ranges and its potential implications for nuclear imaging.

Thank you to everyone who attended the symposium! If you are at ECMP, make sure to connect with Gaetan Van Simaeys to continue the conversation and learn more about Spectrum Dynamics Medical.

European Federation of Organisations for Medical Physics